COST three-lens brief
Evidence-based stock research on COST. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 9.6pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 9.6pp over 30 days.
- Analyst mean target $1080.33 — 19% above current (33 analysts).
COST closed at $911.37 (-0.18%) as of 2026-07-10. Market cap: $404.17B. P/E (trailing) 45.8. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $1080.33 — 19% above current (33 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 9.6pp over 30 days.. Last quarter: Revenue $70.53B, net income $2.19B, free cash flow $6.95B.
Why three lenses on COST, not one.
A single reasoning model has blind spots it doesn’t know about. We examine COSTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/COST" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath COST brief"></iframe>